[144] Vistra Corp. SEC Filing
Vistra Corp. Form 144 summary: This Form 144 notifies proposed sales of 21,374 common shares held by a person associated with Vistra (VST). The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $4,335,603.70 and an approximate sale date of 09/12/2025. The shares reported as to be sold were acquired on the same date by exercise of options originally granted on 10/11/2016 (19,200 shares) and 04/09/2018 (2,174 shares), with cash payment reported. The filer also reported recent sales by the same person of 19,592 shares on 09/10/2025 for $3,933,635.75 and 43,074 shares on 09/11/2025 for $8,991,625.77.
- Compliance disclosure filed as LIVE and includes broker, exchange, acquisition dates, and payment method.
- Acquisition method disclosed: shares were acquired via option grants dated 10/11/2016 and 04/09/2018, with payment in cash.
- Large insider selling activity: recent reported sales total 62,666 shares for approximately $12.9 million in gross proceeds.
- Additional proposed sale of 21,374 shares valued at $4,335,603.70 scheduled for 09/12/2025 may further increase insider share disposals.
Insights
TL;DR: Insider has executed and is proposing large option-based share sales over consecutive days, producing multi-million dollar proceeds.
The filing documents option exercises and immediate disposition through a broker on the NYSE. The notice quantifies the proposed sale (21,374 shares; $4.34M) and discloses two prior recent sales totaling 62,666 shares and roughly $12.9M in gross proceeds. From a securities-transaction perspective, this is a routine Rule 144 disclosure of a registered-person sale after option exercise, but the magnitude and timing of consecutive transactions are material to shareholders monitoring insider liquidity. The filing includes acquisition dates and payment method (cash) consistent with standard reporting requirements.
TL;DR: Proper Rule 144 notice filed showing option-originated holdings and sequential sell orders; procedural compliance is evident.
The form identifies the broker, exchange, class of security, acquisition via options (2016 and 2018 grants), and certifies no undisclosed material adverse information. The disclosure of recent sales on 09/10/2025 and 09/11/2025 provides a clear history of dispositions required for aggregation under Rule 144. The statement attesting to the absence of undisclosed material information and the inclusion of transaction details indicate the filer followed the intended compliance process for insider sales.